(R) -Zevaquenabant
Product Specifications
Target
Cannabinoid Receptor, NO Synthase
Related Pathways
Immunology/Inflammation, GPCR/G Protein
Bioactivity
(R) -Zevaquenabant ((R) -MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S) -MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS) . It is beneficial in improving chronic kidney disease (CKD) caused by obesity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
